Physician profile
Mark Adelman
NPI 1952395642
$3,790.69
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,356 · 2021: $74.80 · 2022: $601 · 2023: $908 · 2024: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,123.46 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Bard Peripheral Vascular, INC. | $975.42 | 2019-2024 | Lutonix Drug Coated Balloon, Crosser Iq |
| Baxter Healthcare | $972.24 | 2019 | |
| Cook Medical LLC | $264.01 | 2023-2024 | Zilver Ptx, Zenith Spiral-Z |
| Inari Medical, INC. | $215.26 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Getinge USA Sales, LLC | $112.06 | 2019 | |
| Shape Memory Medical INC. | $74.80 | 2021 | |
| Boston Scientific Corporation | $53.44 | 2024 | Varithena Administration Pack |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Adelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.